Literature DB >> 26209266

Synthesis and antifungal evaluation of head-to-head and head-to-tail bisamidine compounds.

Son T Nguyen1, Steven M Kwasny1, Xiaoyuan Ding1, John D Williams1, Norton P Peet1, Terry L Bowlin1, Timothy J Opperman2.   

Abstract

Herein, we describe the antifungal evaluation of 43 bisamidine compounds, of which 26 are new, having the scaffold [Am]-[HetAr]-[linker]-[HetAr]-[Am], in which [Am] is a cyclic or acyclic amidine group, [linker] is a benzene, pyridine, pyrimidine, pyrazine ring, or an aliphatic chain of two to four carbon, and [HetAr] is a 5,6-bicyclic heterocycle such as indole, benzimidazole, imidazopyridine, benzofuran, or benzothiophene. In the head-to-head series the two [HetAr] units are oriented such that the 5-membered rings are connected through the linker, and in the head-to-tail series, one of the [HetAr] systems is connected through the 6-membered ring; additionally, in some of the head-to-tail compounds, the [linker] is omitted. Many of these compounds exhibited significant antifungal activity against Candida albicans, Candida krusei, Candida glabrata, Candida parapsilosis, and Cryptococcus neoformans (MIC ⩽ 4 μg/ml). The most potent compounds, for example, P10, P19 and P34, are comparable in antifungal activities to amphotericin B (MIC 0.125 μg/ml). They exhibited rapid fungicidal activity (>3 log10 decrease in cfu/ml in 4h) at concentrations equivalent to 4× the MIC in time kill experiments. The bisamidines strongly inhibited DNA, RNA and cell wall biosynthesis in C. albicans in macromolecular synthesis assays. However, the half-maximal inhibitory concentration for DNA synthesis was approximately 30-fold lower than those for RNA and cell wall biosynthesis. Fluorescence microscopy of intact cells of C. albicans treated with a bisamidine exhibited enhanced fluorescence in the presence of DNA, demonstrating that the bisamidine was localized to the nucleus. The results of this study show that bisamidines are potent antifungal agents with rapid fungicidal activity, which is likely to be the result of their DNA-binding activity. Although it was difficult to obtain a broad-spectrum antifungal compound with low cytotoxicity, some of the compounds (e.g., P9, P14 and P43) exhibited favorable CC50 values against HeLa cells and maintained considerable antifungal activity.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antifungal; Bisamidines; Candida; Cryptococcus; DNA binding; Fungicidal

Mesh:

Substances:

Year:  2015        PMID: 26209266      PMCID: PMC4554983          DOI: 10.1016/j.bmc.2015.07.006

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  15 in total

Review 1.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 2.  Antiparasitic compounds that target DNA.

Authors:  W David Wilson; Farial A Tanious; Amanda Mathis; Denise Tevis; James Edwin Hall; David W Boykin
Journal:  Biochimie       Date:  2008-03-04       Impact factor: 4.079

3.  Synthesis and antibacterial evaluation of new, unsymmetrical triaryl bisamidine compounds.

Authors:  Son T Nguyen; John D Williams; Michelle M Butler; Xiaoyuan Ding; Debra M Mills; Tommy F Tashjian; Rekha G Panchal; Susan K Weir; Chaeho Moon; Hwa-Ok Kim; Jeremiah A Marsden; Norton P Peet; Terry L Bowlin
Journal:  Bioorg Med Chem Lett       Date:  2014-06-12       Impact factor: 2.823

4.  Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.

Authors:  R R Tidwell; J D Geratz; E J Dubovi
Journal:  J Med Chem       Date:  1983-02       Impact factor: 7.446

Review 5.  Changing patterns and trends in systemic fungal infections.

Authors:  Malcolm D Richardson
Journal:  J Antimicrob Chemother       Date:  2005-09       Impact factor: 5.790

6.  Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.

Authors:  Michelle M Butler; William A Lamarr; Kimberly A Foster; Marjorie H Barnes; Donna J Skow; Patrick T Lyden; Lauren M Kustigian; Chengxin Zhi; Neal C Brown; George E Wright; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

Review 7.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.

Authors:  Benjamin J Park; Kathleen A Wannemuehler; Barbara J Marston; Nelesh Govender; Peter G Pappas; Tom M Chiller
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

Review 8.  Current challenges in the management of invasive fungal infections.

Authors:  Chih-Cheng Lai; Che-Kim Tan; Yu-Tsung Huang; Pei-Lan Shao; Po-Ren Hsueh
Journal:  J Infect Chemother       Date:  2008-04-30       Impact factor: 2.211

9.  Rapamycin (AY-22,989), a new antifungal antibiotic. IV. Mechanism of action.

Authors:  K Singh; S Sun; C Vézina
Journal:  J Antibiot (Tokyo)       Date:  1979-06       Impact factor: 2.649

10.  Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agents.

Authors:  M Del Poeta; W A Schell; C C Dykstra; S Jones; R R Tidwell; A Czarny; M Bajic; A Kumar; D Boykin; J R Perfect
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

View more
  1 in total

1.  DNA Targeting as a Likely Mechanism Underlying the Antibacterial Activity of Synthetic Bis-Indole Antibiotics.

Authors:  Timothy J Opperman; Steven M Kwasny; Jessica Bo Li; Mark A Lewis; Daniel Aiello; John D Williams; Norton P Peet; Donald T Moir; Terry L Bowlin; Eric C Long
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.